Search PubMed⌕ Search

Biomedical subjects

S Eriksson

Publications and source records attributed to S Eriksson.

At least 469 records · Page 26Linked to original sources
PubMed1981

Tuberculous meningitis: immune reactions within the central nervous system.

Cerebrospinal fluid (CSF) lymphocytes from two patients with tuberculous meningitis proliferated stronger than the corresponding peripheral blood lymphocytes (PBL) when stimulated with tuberculin purified protein derivative (PPD) in the lymphocyte transformation test after 3 days of culture. This might indicate an accumulation of specifically primed lymphocytes within the central nervous system. CSF lymphocytes and PBL from nine of ten patients with acute aseptic meningitis investigated as controls showed no or low responses when stimulated with PPD, whereas the remaining patient displayed a significant proliferation of CSF lymphocytes, which was more pronounced than that of PBL. Stimulation with the mitogens phytohaemagglutinin, concanavalin A, and pokeweek mitogen gave lower proliferation of CSF lymphocytes compared with PBL in tuberculous and aseptic meningitis. Evaluation of the proliferative response of CSF lymphocytes compared with PBL on stimulation with PPD might be a useful complement in the diagnosis of tuberculous meningitis.

Adolescent↗
PubMed1981

Cerebral sodium/angiotensin interaction studied by RIA-determination of urinary arginine vasopressin in the hydrated goat.

Radioimmunoassay determination of urinary arginine vasopressin (AVP) was employed to study quantitatively cerebral Na+/angiotensin II (A II) interaction in the hydrated goat. The solutions infused for 30 min at 0.02 ml/min into the lateral cerebral ventricle were: a) Hypertonic (0.25 M) NaCl, b) AII (0.3 ng/kg min) in isotonic (0.15 M) NaCl, and c) A II (doses as in b) in 0.25 M NaCl. The mean amounts of AVP detected in the urine in response to the various infusions were: a) 2.8 ng, b) 3.6 ng, and c) 13.3 ng. Thus, the A II/NaCl stimulation induced a detected renal excretion of AVP that was two times as large as the sum of the effects recorded in response to separate stimuli. Infusion c) invariably induced a pronounced, long-lasting inhibition of the water diuresis, intense thirst, and natriuresis. The corresponding effects of infusions a) and b) were much weaker and, as regards thirst and natriuresis, inconsistent. The determinations of renal AVP excretion provide additional, and rather direct evidence for the concept of a synergistic action of elevated cerebrospinal fluid [Na+] and A II as concerns cerebral control of fluid balance. With regard to this kind of interaction, the observed dipsogenic and natriuretic effects mainly confirm earlier observations.

Angiotensin II↗
PubMed1981

Drinking in goats as effect of simultaneous intravenous infusions of angiotensin (I or II) and hypertonic NaCl or mannitol.

Drinking during the simultaneous intravenous infusion of angiotensin I (AI) or II (AII) and hypertonic NaCl or mannitol was studied in the goat, and was compared to the dipsogenic responses to the separate infusion of each of these four factors. Approximately the same amount of water was drunk during the infusion of AI/NaCl, AI/mannitol and AII/NaCl. The amount was roughly equal to the sum of the amounts taken when each of two paired stimuli was infused separately. Significantly less water was drunk in response to AII/mannitol. Somewhat more water was drunk during the separate AI than during the separate AII infusion. Administration of an AI converting enzyme inhibitor completely abolished the AI contribution to drinking during the AI/NaCl infusion but did not reduce AII/NaCl drinking, indicating that the response to AI was entirely due to its conversion into AII. The possibility is discussed that the considerable difference between AI/mannitol and AII/mannitol drinking might have been the result of choroidal and/or ependymal AI converting enzyme activity.

Angiotensin I↗
PubMed1981

Intra- and extracellular alpha 1-antitrypsin in liver disease with special reference to Pi phenotype.

In order to study the relation between intra- and extrahepatocellular alpha 1-antitrypsin (alpha 1-AT) concentrations in patients with various Pi phenotypes, a prospective series of needle liver biopsies was stained with both periodic acid-Schiff (PAS) and a specific immunoperoxidase technique to demonstrate intracellular alpha 1-AT. Concomitant blood samples from all patients were analysed for alpha 1-AT. Pi phenotypes were determined by isoelectric focusing. Non-globular intrahepatocellular alpha 1-AT can be seen in biopsies from Pi M patients with increased plasma alpha 1-AT concentrations and active liver disease. No evidence was found in this study of 250 patients (including 22 controls) for predisposition toward liver disease in any phenotypic group. PAS or immunoperoxidase staining (or both) for alpha 1-AT demonstrated characteristic globular inclusions in 11 of 15 cases having the Z allele, one case being diffusely positive and three negative. Biopsies from 3 of 207 patients with liver disease and lacking the Z allele had globular inclusions seen with both PAS and immunoperoxidase techniques. alpha 1-AT globules in absence of the Z allele are most often found in elderly patients with severe disease and high plasma alpha 1-AT concentrations.

Adult↗
PubMed1981

Effect of 1 alpha-hydroxycholecalciferol on bone mass and composition of cortical bone in adult male rats.

High daily oral doses of 10 micrograms 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) administered to adult rats produced toxic effects such as loss of body weight, hypercalcemia and bone resorption. However, small (0.09 microgram) and moderate (0.9 microgram) daily doses of 1 alpha-OHD3 did not produce toxic effects during six weeks of observation. Serum calcium level was only slightly raised, but bone mass, bone mineral and organic matter contents, including collagen and nucleic acids of the cortical bone matrix, significantly increased, while the amount of glycosaminoglycans was reduced. Treatment with small daily doses of 1 alpha-OHD3 (0.09 microgram/day for six weeks) produced a more pronounced effect on the variables studied than did the moderate dosage (0.9 microgram). 1 alpha-OHD3 promotes new bone formation in the mature rat skeleton after conversion to 1,25 dihydroxycholecalciferol [1,25(OH)2D3] in the liver, probably by exerting a direct effect on bone tissue rather than through indirect hormonal events.

Administration, Oral↗
PubMed1981

[Background and experience of adjuvant cytostatic therapy in gastrointestinal cancer (author's transl)].

Survival rates for patients with colorectal cancer have remained unchanged during the last 30 years. Every third patient with colon cancer Dukes' C and every fourth patient with rectal cancer Dukes' C survives 5 years. Of the patients who succumb to colorectal cancer, 85% will die within 3 years from diagnosis. There are many studies concerning the mechanisms of adjuvant chemotherapy. Its effectiveness has been proven in animal experiments. Micrometastases have a large growth fraction, few non-proliferative cells, and because of this, increased sensibility to cytostatics. Adjuvant chemotherapy aimed at treating occult metastases. In colorectal cancer the combination of 5-FU and Nitrosurea has been shown to have a better effect than 5-FU alone. Grage et al. have shown patients with colorectal cancer Dukes' C to have a longer tumour-free interval with adjuvant 5-FU, and this treatment gives patients with rectal cancer a prolonged survival time. In an adjuvant study, peroral 5-FU 90 days versus placebo did not show any effect. In another adjuvant study Vincristin, CCNU and 5-FU treated patients had fewer tumour recurrences than control patients. The observation time is, however, rather short. Adjuvant chemotherapy for colorectal cancer has shown promising results and it is hoped that further attempts with other forms of cancer in the gastrointestinal tract will also yield the same results.

Antineoplastic Agents↗
PubMed1980

Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects.

1. L-Leucine was given to healthy, post-absorptive subjects as a continuous intravenous infusion (300 mumol/min) during 2 1/2 h. Arterial blood concentrations and regional exchange amino acids were measured across the splanchnic region, the brain and a leg, by the catheter technique. Renal clearance of amino acids was also determined. 2. During the infusion of leucine its concentration rose four- to six-folds, while the concentrations of several other amino acids declined continually, the effect being most pronounced for isoleucine (-55% of initial value), methionine (-55%), valine (-40%), tyrosine (-35%) and phenylalanine (-35%). 3. The infused leucine was taken up by muscle tissue (55%), by the splanchnic region (25%) and by the brain (10%). Neither leg-muscle release nor splanchnic uptake of aromatic amino acids was affected. Renal clearance and tubular reabsorption of amino acids were uninfluenced by leucine infusion. The uptake of isoleucine and methionine by the brain, seen in the basal state, was inhibited during leucine infusion. 4. The marked reduction in the concentrations of the aromatic amino acids, the uptake of leucine by the brain and the inhibition of brain methionine uptake, which accompany leucine infusion in healthy subjects, may be of relevance for the treatment of patients with portal-systemic encephalopathy.

Abdomen↗
PubMed1980

Alpha 1-antitrypsin and other acute phase reactants in liver disease.

The plasma acute phase reactant pattern was studied in 124 patients with liver disease and 16 healthy individuals undergoing liver biopsy, alpha 1-Antitrypsin levels were found to correlate positively with the extent of hepatocellular damage, inflammatory activity and total biopsy score. Haptoglobin levels correlate negatively with these parameters and particularly with characteristics conducive to portal hypertension. Orosomucoid and fibrinogen were unaffected by extent of disease and activity. These changes result in a typical acute phase reactant pattern, seen most frequently in viral hepatitis and chronic active hepatitis and less frequently in alcoholic liver disease. When present, it has a high specificity and predictive value for detection of liver disease.

Electrophoresis, Agar Gel↗
PubMed1980

Isolation and characterization of profilactin and profilin from calf thymus and brain.

1. Profilactin and profilin have been purified from calf thymus and calf brain. Thymus profilactin could be crystallized with a similar technique as described earlier for the spleen protein. 2. Preparations of profilactin from the three calf tissues spleen, thymus and brain contain a mixture of beta actin and gamma actin. The ratio beta/gamma differs between the tissues, but is constant throughout the purification steps. 3. The properties of profilin isolated from three sources (spleen, thymus and brain) indicate that it is a highly conserved protein.

Actins↗
PubMed1980

alpha-Actinin promotes polymerization of actin from profilactin.

The effect of alpha-actinin on profilactin has been analyzed. The results show that addition of submolar ratios of alpha-actinin to a profilactin sample leads to a dissociation by the profilin-actin complex and polymerization of actin. The newly formed filaments are cross-linked by alpha-actinin.

Actinin↗
PubMed1980

Use of isotope dilution--mass spectrometry for accuracy control of different routine methods used in clinical chemistry.

Serum from patients was pooled, filtered, dispensed and frozen. The serum pool obtained was used for accuracy control in twenty-one participating laboratories in the Stockholm area. Mean values (state of art values) were obtained for creatinine, cholesterol, glucose, urea and uric acid. These values were compared with values obtained with highly accurate reference methods, based on isotope dilution--mass fragmentography. The most marked difference was found in the case of determination of creatinine. It is suggested that immediate access to such a well-defined human serum might decrease the need for conventional interlaboratory control programmes.

Blood Glucose↗